Our Team

Solve M.E. Team

Oved Amitay is the Chief Executive Officer of Solve M.E.

Oved has dedicated most of his professional career to the development of life-changing therapeutic options for people affected by rare genetic diseases. Throughout his career, Oved had extensive engagements with healthcare systems and patient advocacy organizations around the world, forging collaborations to address the needs of people affected by rare genetic diseases. 

Oved is a registered pharmacist, trained at the School of Pharmacy, Hebrew University in Jerusalem, and holds a M.Sc. in Pharmacology from Northeastern University in Boston. He has a certificate from the program for Critical and Creative Thinking at the University of Massachusetts Boston. Oved also has more than twenty years of leadership experience as an officer in the Israeli Defense Forces.

Oved served as Chief Business Officer at CENTOGENE (NASDAQ: CNTG), a global leader in the diagnostics of rare hereditary disorders where his overall responsibility for the company´s programs with the biotechnology and pharmaceutical industry included enhancing existing partnerships and establishing new collaborations to facilitate drug development and improve treatment outcomes. He is also a Founding Advisor of Splisense Therapeutics, Israel.

David Hardy, MD is Medical Advisor at Solve M.E.

Dr. Hardy is an infectious disease specialist, and in addition to caring for patients for over 30 years, his work has focused on developing novel treatments, vaccines, cures, and remission strategies for human viral diseases.

Since 1984, Dr. Hardy has amassed expertise as an HIV/AIDS care provider, researcher and advocate. His research has focused on treatment and prevention of opportunistic infections, immune therapies, as well as cellular and gene therapies as strategies for cure of HIV infection and other viral diseases.

Dr. Hardy has taught at UCLA’s David Geffen School of Medicine, Cedars-Sinai Medical Center, Johns Hopkins University School of Medicine, and most recently at USC’s Keck School of Medicine. He received his medical degree from Baylor College of Medicine, Houston, TX and completed his residency in internal medicine at Harbor-UCLA Medical Center in Torrance, California as well as clinical and laboratory fellowships at UCLA School of Medicine.

Leslie L. Philips, PhD is the consulting Director of Product Management and Operations at Solve M.E.

She is an epidemiologist specializing in clinical epidemiology, research study design and analysis, and best practices for data collection, Leslie is accomplished in helping organizations navigate complex epidemiologic questions, providing insight and support to better understanding the ME/CFS landscape. Leslie holds a Master’s Degree in Public Health from Harvard University and a Doctorate in Epidemiology from the University of Washington. She has served in a variety of analytic and leadership capacities in research and public health and, in addition to epidemiology, has expertise in survey research, health equity, population health, and Lean Startup methodologies.

At Solve, Leslie is focused on “getting under the hood” to identify data insights that can be translated into actionable next steps. As a Seattle resident through many a grey, wet winter, Leslie has developed an excessive addiction to coffee and an impressive collection of GORE-TEX.

Kate Mudie is Research Senior Manager at Solve M.E.

Kate’s responsibilities include coordination of the You + ME Registry and Biobank, oversight of data and analyses, and management of the Ramsay Grant Program. With an academic background as a Research Fellow in Epidemiology, Kate brings with her expertise in various aspects of research including study design and analyses, data harmonization, and biobank operation coordination. Kate has worked in ME/CFS research since 2018, assisting with ongoing studies and guiding the development of new studies in collaboration with experts from various fields.

You + ME Innovation Council

The Innovation Council is a key part of the You + ME Community. This group not only reviews proposals for data and biospecimen use but also generates creative ideas for use of the data + innovative approaches to recruiting + retaining participants. The Innovation Council is made up of those with ME/CFS, those with Long Covid, care partners, clinicians, researchers, epidemiologists + those with expertise in AI/machine learning + big data.


Our goal is to create the largest possible ME/CFS and Long Covid dataset in collaboration with an international network of partners.

We are currently working with partners in the United Kingdom + Australia to forge a Global Data Collaborative through which we will work together to share tools + resources + create ways to merge datasets together. Our goal is to expand the Collaborative with new partners over time.

Skip to content